Ingram Micro to Join S&P SmallCap 600 Index Nov. 17
Ingram Micro Holding Corp. will replace Pacira BioSciences in the S&P SmallCap 600 after Viatris acquires Pacira.
Ingram Micro Holding Corp. is set to enter the S&P SmallCap 600 index before markets open on Tuesday, November 17, displacing Pacira BioSciences Inc., which is being acquired by S&P 500 member Viatris Inc., according to an announcement released November 11.
The index change is a direct result of the pending takeover of Pacira BioSciences by Viatris. When a company is acquired and removed from trading, index administrators routinely select a replacement to maintain the benchmark's composition and market-cap representation.
Read more Windward Bio Debuts on Nasdaq, Shares Surge 68% on IPO Day →
Ingram Micro, which trades on the New York Stock Exchange under the ticker INGM, is a global technology distribution and services company. Its inclusion in the small-cap benchmark typically triggers buying activity from index-tracking funds and exchange-traded funds that mirror the S&P SmallCap 600, a dynamic that can influence short-term share price movement around the effective date.
Pacira BioSciences trades on the Nasdaq under the symbol PCRX, while acquirer Viatris carries the ticker VTRS on the same exchange. The transaction underscores continued consolidation activity in the pharmaceutical sector, with larger S&P 500 constituents absorbing smaller specialty drug companies.
Continue reading at All Financial Services & Investing.
